Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Bellerophon, Bioxytran, CSL Vifor, Everest Medicines, Hinova Pharmaceuticals, Inmagene, Medicinova, Takeda.
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Advanz, Aeon, Alvotech, Asieris, Atyr, Chong Kun Dang, Inmune, Kyorin, Merck, Nimbus, Novavax, Revir, Synaffix, Takeda, Thermo Fisher Scientific, Wellmarker.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Certa, Daewoong, Eiger, Essex, Immutep, Immvira, Innocare, Kintor.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Exelixis, Gracell, Iaso, Ironwood, Jubilant, Nrx, Ocuphire, Pfizer, Pharmazz, Sairopa.